Unknown

Dataset Information

0

Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial.


ABSTRACT: Elafin is a potent endogenous neutrophil elastase inhibitor that protects against myocardial inflammation and injury in preclinical models of ischaemic-reperfusion injury. We investigated whether elafin could inhibit myocardial ischaemia-reperfusion injury induced during coronary artery bypass graft (CABG) surgery.In a randomised double-blind placebo-controlled parallel group clinical trial, 87 patients undergoing CABG surgery were randomised 1:1 to intravenous elafin 200?mg or saline placebo administered after induction of anaesthesia and prior to sternotomy. Myocardial injury was measured as cardiac troponin I release over 48?h (area under the curve (AUC)) and myocardial infarction identified with MRI. Postischaemic inflammation was measured by plasma markers including AUC high-sensitive C reactive protein (hs-CRP) and myeloperoxidase (MPO). Elafin infusion was safe and resulted in >3000-fold increase in plasma elafin concentrations and >50% inhibition of elastase activity in the first 24?h. This did not reduce myocardial injury over 48?h (ratio of geometric means (elafin/placebo) of AUC troponin I 0.74 (95% CI 0.47 to 1.15, p=0.18)) although post hoc analysis of the high-sensitive assay revealed lower troponin I concentrations at 6?h in elafin-treated patients (median 2.4 vs 4.1??g/L, p=0.035). Elafin had no effect on myocardial infarction (elafin, 7/34 vs placebo, 5/35 patients) or on markers of inflammation: mean differences for AUC hs-CRP of 499?mg/L/48 h (95% CI -207 to 1205, p=0.16), and AUC MPO of 238?ng/mL/48 h (95% CI -235 to 711, p=0.320).There was no strong evidence that neutrophil elastase inhibition with a single-dose elafin treatment reduced myocardial injury and inflammation following CABG-induced ischaemia-reperfusion injury.(EudraCT 2010-019527-58, ISRCTN82061264).

SUBMITTER: Alam SR 

PROVIDER: S-EPMC4621368 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial.

Alam S R SR   Lewis S C SC   Zamvar V V   Pessotto R R   Dweck M R MR   Krishan A A   Goodman K K   Oatey K K   Harkess R R   Milne L L   Thomas S S   Mills N M NM   Moore C C   Semple S S   Wiedow O O   Stirrat C C   Mirsadraee S S   Newby D E DE   Henriksen P A PA  

Heart (British Cardiac Society) 20150826 20


<h4>Background</h4>Elafin is a potent endogenous neutrophil elastase inhibitor that protects against myocardial inflammation and injury in preclinical models of ischaemic-reperfusion injury. We investigated whether elafin could inhibit myocardial ischaemia-reperfusion injury induced during coronary artery bypass graft (CABG) surgery.<h4>Methods and results</h4>In a randomised double-blind placebo-controlled parallel group clinical trial, 87 patients undergoing CABG surgery were randomised 1:1 to  ...[more]

Similar Datasets

2012-10-12 | E-GEOD-29396 | biostudies-arrayexpress
2012-10-12 | GSE29396 | GEO
| S-EPMC8876254 | biostudies-literature
| S-EPMC4402998 | biostudies-literature
| S-EPMC5107858 | biostudies-literature
| S-EPMC2943860 | biostudies-literature
| S-EPMC2621199 | biostudies-literature